Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TENOFOVIR Cause Intentional product use issue? 31 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Intentional product use issue have been filed in association with TENOFOVIR. This represents 0.8% of all adverse event reports for TENOFOVIR.

31
Reports of Intentional product use issue with TENOFOVIR
0.8%
of all TENOFOVIR reports
20
Deaths
28
Hospitalizations

How Dangerous Is Intentional product use issue From TENOFOVIR?

Of the 31 reports, 20 (64.5%) resulted in death, 28 (90.3%) required hospitalization.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TENOFOVIR. However, 31 reports have been filed with the FAERS database.

What Other Side Effects Does TENOFOVIR Cause?

Foetal exposure during pregnancy (509) Virologic failure (409) Drug resistance (317) Exposure during pregnancy (292) Death (225) Immune reconstitution inflammatory syndrome (177) Maternal exposure during pregnancy (173) Treatment failure (163) Drug interaction (141) Premature baby (126)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which TENOFOVIR Alternatives Have Lower Intentional product use issue Risk?

TENOFOVIR vs TENOFOVIR ALAFENAMIDE TENOFOVIR vs TENOFOVIR DISOPROXIL TENOFOVIR vs TEPLIZUMAB-MZWV TENOFOVIR vs TEPOTINIB TENOFOVIR vs TEPROTUMUMAB

Related Pages

TENOFOVIR Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue TENOFOVIR Demographics